BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25970362)

  • 1. Elective hand surgery after axillary lymph node dissection for cancer.
    Lee RJ; LaPorte DM; Brooks JT; Schubert CD; Deune EG
    Orthopedics; 2015 May; 38(5):e367-73. PubMed ID: 25970362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of elective hand surgery following axillary lymph node dissection for breast cancer.
    Hershko DD; Stahl S
    Breast J; 2007; 13(3):287-90. PubMed ID: 17461904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo Upper Extremity Lymphedema After Elective Hand Surgery in Breast Cancer Survivors.
    Baltzer HL; Harvey J; Fox PM; Moran SL
    Ann Plast Surg; 2017 Jul; 79(1):24-27. PubMed ID: 28187025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphedema Incidence After Axillary Lymph Node Dissection: Quantifying the Impact of Radiation and the Lymphatic Microsurgical Preventive Healing Approach.
    Johnson AR; Kimball S; Epstein S; Recht A; Lin SJ; Lee BT; James TA; Singhal D
    Ann Plast Surg; 2019 Apr; 82(4S Suppl 3):S234-S241. PubMed ID: 30855393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
    Helyer LK; Varnic M; Le LW; Leong W; McCready D
    Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection.
    Nos C; Clough KB; Bonnier P; Lasry S; Le Bouedec G; Flipo B; Classe JM; Missana MC; Doridot V; Giard S; Charitansky H; Charles-Nelson A; Bats AS; Ngo C
    Eur J Surg Oncol; 2016 Dec; 42(12):1827-1833. PubMed ID: 27769634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
    McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
    J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Evaluation of Safety and Patient Outcomes for Hand Surgery following Prior Breast Cancer Treatment: Establishing New Recommendations in Lymphedema.
    Paton M; Kovar A; Iorio ML
    Plast Reconstr Surg; 2020 Feb; 145(2):459-467. PubMed ID: 31985641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elective hand surgery in the breast cancer patient with prior ipsilateral axillary dissection.
    Dawson WJ; Elenz DR; Winchester DP; Feldman JL
    Ann Surg Oncol; 1995 Mar; 2(2):132-7. PubMed ID: 7728566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
    Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
    Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures.
    Sagen A; Kaaresen R; Sandvik L; Thune I; Risberg MA
    Arch Phys Med Rehabil; 2014 May; 95(5):875-81. PubMed ID: 24389401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
    Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
    Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer related lymphedema in patients with different loco-regional treatments.
    Ozcinar B; Guler SA; Kocaman N; Ozkan M; Gulluoglu BM; Ozmen V
    Breast; 2012 Jun; 21(3):361-5. PubMed ID: 22460058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
    Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
    Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients.
    Langer I; Kocher T; Guller U; Torhorst J; Oertli D; Harder F; Zuber M
    Breast Cancer Res Treat; 2005 Mar; 90(1):85-91. PubMed ID: 15770531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elective Hand Surgery in Patients With History of Axillary Node Dissection: Risks and Patient Education.
    Awan MU; Schwartz G; Shifchik A; Harmon S; Malisetyan T
    Cureus; 2022 Jul; 14(7):e27461. PubMed ID: 36051709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of lymphedema in patients with axillary lymph node dissections to those with sentinel lymph node biopsy followed by immediate and delayed ALND.
    Kuwajerwala NK; Feczko C; Dekhne N; Pettinga J; Lucia VC; Riutta J; Vicini F
    Am J Clin Oncol; 2013 Feb; 36(1):20-3. PubMed ID: 22157215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
    McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
    J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequelae following axillary lymph node dissection for breast cancer.
    Sakorafas GH; Peros G; Cataliotti L
    Expert Rev Anticancer Ther; 2006 Nov; 6(11):1629-38. PubMed ID: 17134366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.